Chairman of Lyonbiopole's Board of Directors
Mr. Erick Lelouche has been President of Lyonbiopole since January 29, 2025.
A graduate of the École Nationale Vétérinaire de Nantes and the Institut d’Administration des Entreprises de Montpellier, he built an international career in the pharmaceutical and human and animal health industries after working for several years as a practicing veterinarian.
He notably held various positions in France and later in the United States at Pfizer Animal Health before joining Boehringer Ingelheim France in 2000, where he continued his career for over twenty years. He concluded his professional journey as President of the Boehringer Ingelheim Group in France nearly two years ago.
Since his retirement, Erick remains highly involved in the health sector as a board member of the VetAgro Sup veterinary school, the Bioforce training organization, and as Chairman of Antabio, a biotech company active in the fight against antibiotic resistance. Passionate about innovation and a strong advocate of the “One Health” concept, he brings an ambitious strategic vision and recognized operational expertise to the cluster.